Items tagged with Drug-resistant TB
Tajikistan: Stories from MSF's paediatric TB projects (post)
Delamanid is one of the first new TB medicines in over 50 years, and recently the project team in Dushanbe, Tajikistan's capital, started treating a young TB patient with it. It follows several months of preparations and negotiations with the Ministry of Health and its counterparts.
Early outcomes of decentralized care for rifampicin-resistant TB in Johannesburg, South Africa: an observational cohort study (post)
Abstract
Prevalence of drug-resistant TB in West Africa higher than previously thought (post)
Multidrug-resistant tuberculosis (TB) could become a serious public health threat in West Africa unless effective surveillance and control measures are implemented, according to a study published in the open access journal BMC Medicine. Researchers from the West-African Network of Excellence for TB, AIDS and Malaria (WANETAM) found the prevalence of multidrug-resistant tuberculosis (MDR-TB) to be unexpectedly high in eight West-African countries.
Bill Gates: Let’s make TB history (post)
I visited South Africa earlier this year to learn more about the progress the country is making in the fight against HIV. I toured health clinics, met with doctors and researchers, and listened to the stories of people living with HIV. Again and again, our conversations turned to an often forgotten disease which is HIV’s lethal partner: tuberculosis.
IJTLD December 2016: MDR-TB clinical trials landscape supplement now online (post)
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
Online resource offers platform for clinicians and researchers working on drug-resistant TB (post)
ATLANTA, Ga –An interactive online portal now allows clinicians and researchers across five countries heavily affected by drug-resistant tuberculosis to exchange and analyze information that includes X-rays, scans, genomic information and clinical data that includes types of resistance, co-infections, and outcomes of patients whose disease does not respond to the two most effective TB treatments.
WHO: The use of delamanid in the treatment of MDR-TB in children and adolescents: Interim policy guidance (post)
Multidrug-resistant tuberculosis (MDR-TB) is a public health challenge of growing concern. Approximately 580 000 people acquired MDR-TB in 2015, with children accounting for close to 30 000 of MDR-TB cases.
TB drug resistance in Bamako, Mali, from 2006 to 2014 (post)
Abstract
Person-to-person MDR-TB transmission drives epidemic in China (post)
Recent data from a population-based, observational study in China revealed that patients were more likely to develop multidrug-resistant tuberculosis from person-to-person transmission than from inadequate treatment.
Page 36 of 117 · Total posts: 0
←First 35 36 37 Last→